- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04030897
Promoting Treatment Access Following Pediatric Primary Care Depression Screening
March 5, 2020 updated by: Jessica Schleider, Stony Brook University
Promoting Treatment Access Following Pediatric Primary Care Depression Screening: Evaluation of Web-based, Single-session Interventions for Parents and Youths
Major depression (MD) in youth is a serious psychiatric illness with extensive morbidity and mortality.
The American Academy of Pediatrics recently released practice guidelines promoting primary care (PC)-based youth MD screening; however, even when diagnosed by PC providers, <50% of youth with MD access treatment.
Thus, a need exists for interventions that are feasible for youths and parents to access and complete-and that may strengthen parents' likelihood of pursuing longer-term services.
Single-session interventions (SSIs) may help forward these goals.
SSIs include elements of comprehensive treatments, but their brevity makes them easier to disseminate at scale.
Meta-analytic evidence suggests SSIs can reduce youth psychopathology, including self-administered (e.g., online) SSIs.
One computer-based SSI, teaching growth mindset (GM; viewing personal traits as malleable), has reduced adolescent depressive symptoms in multiple RCTs; GM-SSIs have also improved parents' expectancies that psychotherapy could benefit their children's mental health.
This project will test whether these online, youth- and parent-directed GM-SSIs-designed to reduce youth depressive symptoms and improve parents' mental health treatment expectancies, respectively-may increase mental health service access, reduce youth depressive symptoms, and relieve parental stress following PC-based youth MD screening.
Youths reporting elevated MD symptoms at PC visits (N = 200) will receive either Information/Psychoeducation/Referral (IPR) or IPR plus parent- and youth-directed GM-SSIs (IPR+SSI).
The investigators will examine whether IPR+SSI, versus IPR alone, increases MD service access; reduces parental stress; and reduces youth depressive symptoms across three months.
Results may yield a disseminable model for promoting youth treatment access after PC-based depression screening.
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
246
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jessica L Schleider
- Phone Number: 631-632-4131
- Email: jessica.schleider@stonybrook.edu
Study Locations
-
-
New York
-
Stony Brook, New York, United States, 11794-2500
- Recruiting
- Stony Brook University
-
Contact:
- Jessica L Schleider, PhD
- Phone Number: 631-632-4131
- Email: jessica.schleider@stonybrook.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
11 years to 16 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Youth is between the ages of 11 and 16, inclusive, at the time of study recruitment
- Youth reports a Pediatric Symptom Checklist 'Internalizing' score of 5 or higher (out of 10) at her/his most recent pediatric primary care visit at 1 of the 9 Stony Brook University-affiliated clinics participating in this study
- Parent and youth are comfortable with reading and writing in English
- Parent and youth are comfortable with online activity
Exclusion Criteria:
- Parent or youth is not comfortable reading and/or writing in English
- Parent or youth is not comfortable with online activity
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Online Programs + Information/Psychoeducation/Referral (IPR)
Includes 2 online, one-session programs (one for youths; one for parents) and Primary Care-based IPR.
The 30-min, self-administered YOUTH PROGRAM includes: An introduction to the brain and a lesson on neuroplasticity; Testimonials from older youths who describe their views that traits are malleable, due to the brain's plasticity; Further stories by older youths, describing times when they used "growth mindsets" to persevere during social/emotional setbacks; Study summaries noting how/why personality can change; And an exercise in which youths write notes to younger students, using scientific information to explain people's capacity for change.
In the 15-min Qualtrics-based PARENT PROGRAM, parents read 2 scientific passages on (1) the notion that emotions are flexible in youth and adults, and (2) that failure promotes personal growth.
After each passage, parents write a persuasive summary of its main arguments, directed to fellow parents who may benefit from the information.
|
Online, 15-minute self-administered program for parents
Online, 30 minute self-administered program for youths
Other Names:
Usual care at pediatric primary care clinics participating in this study
|
Placebo Comparator: Information/Psychoeducation/Referral (IPR; usual care control)
Information, Psychoeducation and Referral (IPR) represents usual care in the Stony Brook University Hospital's Pediatric Primary Care Division.
Families of a youth with elevated MD symptoms during a PC visit receive a folder containing informational materials about the nature of depression and referrals to providers in their area.
All families in this study will receive PC-based IPR.
|
Usual care at pediatric primary care clinics participating in this study
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mental Health Treatment-Seeking Behavior Checklist
Time Frame: Baseline to 3-month follow-up
|
At baseline and 3-month follow-up, parents will indicate whether they have engaged in each of four treatment-seeking behaviors for their child: researched local mental healthcare providers/agencies for their child; contacted a mental healthcare provider or agency about treatment for their child; contacted child's school regarding mental health supports for their child; and scheduled an appointment OR placed child on a waiting-list with a mental healthcare provider/agency.
Total number of treatment-seeking behaviors between baseline and 3-month follow-up may range from 0 to 4. Individual behaviors are self-reported by parents on as 'yes' or 'no' (noting whether they engaged in the behavior during the study period).
At baseline, parents will report on whether they engaged in these behaviors 'since the child's last doctor's appointment.'
At follow-up, parents will report whether they have engaged in these behaviors 'since their past survey, 3 months ago.'
|
Baseline to 3-month follow-up
|
Change in Children's Depression Inventory 2 - Youth Report Total Score
Time Frame: Baseline to 3-month follow-up.
|
Change in youth reported depressive symptoms, total score derived from 28-item CDI-2.
Scores range from 0-56, with higher scores indicating higher levels of depression.
|
Baseline to 3-month follow-up.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Pediatric Symptom Checklist - Youth-Report Total score
Time Frame: Baseline to 3-month follow-up.
|
Youth-report measure of overall youth psychopathology.
Youth rate 35 items on a 0-2 scale reflecting internalizing, externalizing, and attention-related symptoms.
Scores range from 0 - 70.
Higher scores indicate higher overall symptom severity.
|
Baseline to 3-month follow-up.
|
Change in Pediatric Symptom Checklist- Parent Report Total score
Time Frame: Baseline to 3-month follow-up.
|
Youth-report measure of overall youth psychopathology.
Youth rate 35 items on a 0-2 scale reflecting internalizing, externalizing, and attention-related symptoms.
Scores range from 0 - 70.
Higher scores indicate higher overall symptom severity.
|
Baseline to 3-month follow-up.
|
Change in Pediatric Symptom Checklist- Youth Internalizing Score (parent report)
Time Frame: Baseline to 3-month follow-up.
|
Parent-report measure of overall youth psychopathology.
Parents rate 5 items on a 0-2 scale reflecting internalizing symptoms in their child.
Scores range from 0-10.
Higher scores indicate higher overall symptom severity.
|
Baseline to 3-month follow-up.
|
Change in Beck Hopelessness Scale - 4 (Youth Report)
Time Frame: Baseline to immediate post-online-intervention (in active intervention group only) and 3-month follow-up (between groups).
|
Respondents (youths) report agreement with 4 items indicating levels of hopelessness about the future.
Higher summed scores reflect greater levels of hopelessness, and scores range from 0-12.
|
Baseline to immediate post-online-intervention (in active intervention group only) and 3-month follow-up (between groups).
|
Change in Beck Hopelessness Scale - 4 (Parent Report)
Time Frame: Baseline to immediate post-online-intervention (in active intervention group only) and 3-month follow-up (between groups).
|
Respondents (parents) report agreement with 4 items indicating levels of hopelessness about the future.
Higher summed scores reflect greater levels of hopelessness, and scores range from 0-12.
|
Baseline to immediate post-online-intervention (in active intervention group only) and 3-month follow-up (between groups).
|
Change in Brief Symptom Inventory - 18
Time Frame: Baseline to 3-month follow-up
|
The Brief Symptom Inventory-18 (BSI-18) assesses self reported parent psychopathology and distress.
Adult respondents rate endorsement of 18 physical and emotional complaints on a 0-4 Likert scale.
The total sum score yields an additional total distress score (range: 0-72).
Higher scores indicate higher levels of overall psychological distress.
|
Baseline to 3-month follow-up
|
Change in Barriers to Accessing Care Evaluation (BACE)
Time Frame: Baseline to 3-month follow-up
|
Parents rate the 30 items on a 0-3 scale indicating the degree to which various beliefs, concerns, circumstances, and logistical difficulties have stopped, delayed or discouraged them from getting professional care for their child's mental health problem.
Higher total scores indicate greater perceived barriers to care.
Scores range from 0-90, with higher scores indicating more overall barriers to accessing mental health care for their child.
|
Baseline to 3-month follow-up
|
Change in Attitudes Toward Therapy Scale - Parent
Time Frame: Baseline to immediate post-online-intervention (in active intervention group only) and 3-month follow-up (between groups).
|
One-item measure used to assess parents' perceptions that therapy/counseling would be useful in reducing their child's emotional or behavioral difficulties, rated on a 0-10 scale (total score range: 0-10).
Higher scores indicate stronger beliefs that therapy may help reduce mental health problems, whereas lower scores indicate weaker beliefs that therapy may help reduce mental health problems.
|
Baseline to immediate post-online-intervention (in active intervention group only) and 3-month follow-up (between groups).
|
Mental Health Treatment Access at 3-month follow-up
Time Frame: 3-month follow-up
|
Parents will indicate (yes/no) whether their child has received (a) new and/or (b) continuing school-based, outpatient, or other mental health-related services since the child's recent PC appointment (at baseline) and since the baseline assessment (at 3-month follow-up).
|
3-month follow-up
|
Change in Perceived Stress Scale
Time Frame: Baseline to 3-month follow-up
|
The PSS is a well-validated measure of the degree to which situations in one's life are appraised as stressful, unpredictable, and uncontrollable.
Higher total scores indicate greater overall perceived stress.
The scale includes 10 items rated on a 0-4 scales, and scores range from 0-40.
|
Baseline to 3-month follow-up
|
Change in Pediatric Symptom Checklist - Youth-Report Internalizing Score
Time Frame: Baseline to 3-month follow-up.
|
Youth-report measure of youth depressive symptoms.
Youth rate 5 items reflecting internalizing symptoms on a scale from 0-2.
Total scores range from 0 to 10. Higher scores indicate higher internalizing symptom severity.
|
Baseline to 3-month follow-up.
|
Change in Children's Depression Inventory 2 - Parent Report total score
Time Frame: Baseline to 3-month follow-up.
|
Parent reported youth depressive symptoms, total score derived from 17-item parent-report version of CDI-2.
Scores range from 0-54, and higher scores indicate greater youth depression severity.
|
Baseline to 3-month follow-up.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in implicit theories of emotion scale, parent-report
Time Frame: Baseline to immediate-post-online intervention (active intervention group only)
|
This measure will be used as a manipulation check for parents assigned to the active intervention condition.
Parents will be asked to report the degree to which they view emotions as malleable (versus immutable) at pre- and post-intervention using a previously validated, 4-item assessment of emotion mindsets in adults.
Four items are rated using a 1-to-6 Likert scale.
Higher mean scores on these items indicate a stronger fixed emotion mindset, a lower scores, a stronger growth emotion mindset (range: 1-).
|
Baseline to immediate-post-online intervention (active intervention group only)
|
Change in Implicit Theories of Personality Questionnaire, youth-report
Time Frame: Baseline to immediate-post-online intervention (active intervention group only)
|
This measure will be used as a manipulation check for youths assigned to the active intervention condition.
Respondents rate the extent of their agreement with three statements linked to the malleability of personality, using a 1-to-6 Likert scale (e.g.
"Your personality is something about you that you can't change very much").
Higher mean scores on these three items indicate a stronger fixed personality mindset, a lower scores, a stronger growth personality mindset (range: 1-6).
|
Baseline to immediate-post-online intervention (active intervention group only)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2020
Primary Completion (Anticipated)
April 30, 2021
Study Completion (Anticipated)
August 30, 2021
Study Registration Dates
First Submitted
July 20, 2019
First Submitted That Met QC Criteria
July 23, 2019
First Posted (Actual)
July 24, 2019
Study Record Updates
Last Update Posted (Actual)
March 6, 2020
Last Update Submitted That Met QC Criteria
March 5, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB2019-00241
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
De-identified individual-level participant data will be made publicly available on Open Science Framework upon completion of the grant period (August 2021).
IPD Sharing Time Frame
Study protocol and a statistical analysis plan have been uploaded with this pre-registration.
IPD Sharing Access Criteria
Materials will be publicly available on clinicaltrials.gov.
IPD will be made publicly available on Open Science Framework upon completion of the grant period (August 2021)
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Lawson Health Research InstituteTerminated
Clinical Trials on Parent-Directed Online Single-Session Program
-
Child Mind InstituteStony Brook UniversityUnknownBehavioral Symptoms | Mental Disorders | Depressive Disorder | Depression | Mood DisordersUnited States
-
Royal Holloway UniversitySuspendedDepression | Anxiety Disorders | Anxiety | Low MoodUnited Kingdom
-
Sabri HergünerNot yet recruitingAutism Spectrum Disorder | Behavior Problem of Childhood and Adolescence | EarthquakeTurkey
-
University of California, IrvineJacobs FoundationCompletedDepression | Stress | Anxiety | Loneliness | Distress, Emotional | Mental Health IssueUnited States
-
The Cleveland ClinicCompletedDepression | Anxiety | Psychological StressUnited States
-
University of ManitobaCompletedPerinatal Depression | Perinatal AnxietyCanada
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
University at AlbanyChildren's Hospital of PhiladelphiaNot yet recruitingCraving | Binge Eating | Eating Disorders | Perinatal Problems | Pregnancy Weight Gain